Authors


Patrick P. Gleason, PharmD, BCPS, FCCP

Latest:

A Linezolid Prior Authorization Program: Clinical and Economic Outcomes

This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.


Martha Quintana, BSN, RN,

Latest:

Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing Barriers

This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.


Jennifer G. Allen

Latest:

How Many Americans with High Cholesterol Could be Eligible for PCSK9 Inhibitors?

Specialty drug costs for 13 to 23 million patients in the United States would be $185 to 342 billion.


Con Lane

Latest:

Sponsored Content: Expand Your Pharmacy Footprint

With national brand recognition and expert support, pharmacy franchise owners reach more patients.


Janet Shin, PharmD

Latest:

Impact of Drug Therapy Duration in Patients With Hepatitis C

Adherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.


Ruby Mhajan, RPh

Latest:

Specialty Drugs: Year in Review 2017 Part II

The second part of a comprehensive review of the specialty pharmaceuticals approved by the FDA in 2017.






Allen Amedume, PharmD Candidate 2021

Latest:

The Impact of COVID-19 on Medical Science Liaisons

Most notably, COVID-19 has transformed the landscape for medical science liaisons (MSLs) by forcing them to rapidly adapt to the present circumstances.


George Citroner

Latest:

Millennials Not Receiving HIV Tests

Half of millennial-aged men and women said they have never been tested for HIV outside of blood donation.


Joe Thomas, PharmD, MSPBA Candidate

Latest:

Specialty Pharmacy: Ignoring What It Is and Making It What We Want

Current definitions attempting to summarize specialty pharmacy fall short.



Robert F. Gaudette, PharmD, MBA Candidate 2016

Latest:

The Deadly "Sins" of Vaccinations: Avoiding Bloodborne Diseases

As pharmacists administer more vaccines, the risks of needle-stick injury and transmission of a bloodborne disease increase among pharmacists.


Sandeep Chaudhari, MS

Latest:

Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis Patients

Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.



April S. Brown, PharmD, RPh

Latest:

Understanding Vaccine Billing Changes for 2008

Recently announced changes in vaccine reimbursement under Medicare have implications for pharmacy billing processes.


Timothy O'Shea, MS, PharmD

Latest:

Overview of the Biosimilar Landscape

Biosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.




T. Joseph Mattingly II

Latest:

PharmD/MBA DEGREE: A PERFECT COMBINATION FOR ME...AND YOU?

Mr. Mattingly is a third-year professional student in the PharmD Program at the University of Kentucky College of Pharmacy and is dually enrolled in the MBA Program at the Gatton College of Business and Economics.


Hayato DeLellis, PharmD candidate

Latest:

Early Screening Is Key in Colorectal Cancer

New treatments with biological agents and vaccines are creating a pathway for patients with metastatic CRC.


Giang Ho, PharmD Candidate

Latest:

Graphic Pharmacy: A Student's Journey in Comics

Read the latest pharmacy comic from Giang Ho!


Samuel L. Ellis, PharmD, BCPS

Latest:

Advancing the Management of Diabetes: An Update on New Guidelines and Treatment Options

Pharmacists can learn about current management of type 2 diabetes mellitus, including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.


Katie Eder, Senior Editor

Latest:

7 OTC Product Categories Completely Covered by Insurance

Did you know that health plans completely cover certain OTC products when patients present a prescription?


Jennifer N. Clements, PharmD, BCPS, CDE

Latest:

Lipid Management When Converting Fluvastatin to Pravastatin: Medication Use Evaluation

There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.


Millie Mo, PharmD, BCPS

Latest:

Precision Medicine and the Pharmacist’s Role as a Trusted Counselor in Specialty Pharmacy

The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.


Keith Overfield

Latest:

Long-Term Care: Expanding Into the Market

Demonstrating success is critical to building a long-term care business. How can your pharmacy make a difference?


Edna Bowser, CPhT

Latest:

Joining a Pharmacy Organization Yields Benefits

Gaining the most value from membership requires active participation by techs and a willingness to go outside their comfort zones.